Biomarker Study of ATH434 in Participants With MSA
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT05864365 |
|
Recruitment Status :
Enrolling by invitation
First Posted : May 18, 2023
Last Update Posted : February 7, 2024
|
Sponsor:
Alterity Therapeutics
Information provided by (Responsible Party):
Alterity Therapeutics
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Enrolling by invitation |
|---|---|
| Estimated Primary Completion Date : | February 14, 2025 |
| Estimated Study Completion Date : | February 28, 2025 |